Nicketta McPherson
Physician Assistant · Bronx, NYNPI 1891039756
Payments from drug & device makers
Across 250 payments — averaging $71.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$12K
- Viiv Healthcare Company$3K
- AbbVie$2K
- Novo Nordisk$670
- Theratechnologies Inc.$177
- Alkermes, Inc.$142
- plus $347 from 6 others
What the payments were for
- Consulting fees$3,61020%
- Speaking & faculty fees$3,91122%
- Travel & lodging$1,5168%
- Food & beverage$8,83449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 117 | $12,413 |
| Viiv Healthcare Company | 70 | $2,530 |
| AbbVie | 40 | $1,593 |
| Novo Nordisk | 8 | $670 |
| Theratechnologies Inc. | 3 | $177 |
| Alkermes, Inc. | 2 | $142 |
| GSK | 5 | $132 |
| Merck | 1 | $125 |
| Johnson & Johnson | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,871 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 15 | $57,872 |
| DescovyEmtricitabine/Tenofov Alafenam | 26 | $55,263 |
| JardianceEmpagliflozin | 19 | $12,403 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 121 | $4,377 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,038 |
| Atorvastatin Calcium | 157 | $1,031 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 12 | $1,018 |
| Chlorthalidone | 55 | $833 |
| Metformin Hcl | 97 | $421 |
| Diclofenac Sodium | 17 | $415 |
| Gabapentin | 32 | $337 |
| Amlodipine Besylate | 74 | $327 |
| Metoprolol Succinate | 23 | $284 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 21 | $242 |
| Omeprazole | 24 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $12,413 | $113,13541 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Bronx
- Henry YuBronx$1M
- Julius NwosuBronx$256K
- George LopezBronx$46K
- Kimberley RubinoBronx$29K
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.